The aim of this biospecimen repository is to evaluate an individual's genotype, identify the variances, and understand how they relate to treatment with clopidogrel.
The objective of this project is to distinguish genetic profiles that will assist a practitioner in determining the right dose or alternate medication for the patient. In partnership with the genetics team of the Avera Institute for Human Genetics and physicians with the Avera Heart Hospital of South Dakota and North Central Heart Institute, the research team will perform genetic analysis to identify genetic variances.
Study Type
OBSERVATIONAL
Enrollment
130
Utilizing pharmacogenomics to determine the most effective treatment
Avera Institute for Human Genetics
Sioux Falls, South Dakota, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.